We are a science-based and collaborative CDMO that supports pharmaceutical development from early development to commercialization. The focus of our work is to help customers move from complex scientific and manufacturing challenges to a clear and reliable path.

During the development of medicines, several simultaneous issues often need to be solved: how to develop the active substance and pharmaceutical form, how to ensure the necessary analytical support, and how to lead processes to firmly scalable production. This is particularly important when it comes to complex molecules, controlled substances or generic active substances requiring quality.

We offer development and production services for active substances, pharmaceutical forms, analysis and peptides and oligonucleotides, as well as support for the production of highly potent and controlled substances and generic APIs. Our role is to help customers reduce technical and transmission risks, support regulatory needs and ensure that materials and data are suitable for different stages of development and production.

We are distinguished by teams of scientists, experience with complex molecules and demanding processes, and wide support throughout the life cycle of the medicinal product. We are working to ensure that biotech, pharmaceutical and generic pharmaceutical companies can move faster from development to reliable and quality-oriented production.